Relmada Therapeutics, Inc. (RLMD) Earnings
NASDAQ·Healthcare·Biotechnology
$6.81
+4.37%
Mkt Cap $436.33M
EPS — Estimate vs Actual
Mkt Cap
$436.33M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11
NASDAQ·Healthcare·Biotechnology
$6.81
+4.37%
Mkt Cap $436.33M
Mkt Cap
$436.33M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$1.11